These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1113858)

  • 41. Acetylcholine receptor: modification of synaptic gating mechanism after treatment with a disulfide bond reducing agent.
    Ben-Haim D; Dreyer F; Peper K
    Pflugers Arch; 1975 Mar; 355(1):19-26. PubMed ID: 1080270
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Morphine impairs acetylcholine release but facilitates acetylcholine action at a skeletal neuromuscular junction.
    Frederickson RC; Pinsky C
    Nat New Biol; 1971 May; 231(20):93-4. PubMed ID: 5281099
    [No Abstract]   [Full Text] [Related]  

  • 43. Ionic permeability changes induced by some cholinergic agonists on normal and denervated frog muscles.
    Feltz A; Mallart A
    J Physiol; 1971 Oct; 218(1):101-16. PubMed ID: 4331819
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Iontophoretic application of acetylcholine: advantages of high resistance micropipettes in connection with an electronic current pump.
    Dreyer F; Peper K
    Pflugers Arch; 1974 Apr; 348(3):263-72. PubMed ID: 4857964
    [No Abstract]   [Full Text] [Related]  

  • 45. Differential effects of perhydrohistrionicotoxin on neurally and iontophoretically evoked endplate currents.
    Albuquerque EX; Gage PW
    Proc Natl Acad Sci U S A; 1978 Mar; 75(3):1596-9. PubMed ID: 206910
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of drugs and antibodies on the post-synaptic membrane of the neuromuscular junction.
    Peper K; Sterz R; Bradley RJ
    Ann N Y Acad Sci; 1981; 377():519-43. PubMed ID: 6978665
    [No Abstract]   [Full Text] [Related]  

  • 47. [Study of cholinergic sensitivity at the neuromuscular junction, definition and role of a calcic operant].
    Lièvremont M; Pascaud M
    C R Acad Hebd Seances Acad Sci D; 1972 Feb; 274(9):1345-8. PubMed ID: 4625632
    [No Abstract]   [Full Text] [Related]  

  • 48. Spin labeled acetylcholine analogs: studies of cholinergic receptor.
    Rosen GM; Abou-Donia MB; Yeh JZ; Menzel DB
    Res Commun Chem Pathol Pharmacol; 1975 Oct; 12(2):317-29. PubMed ID: 172996
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Calcic response and cholinergic sensitivity at the neuromuscular junction].
    Lievremont M; Pascaud M
    J Physiol (Paris); 1972 Oct; 65():Suppl:264A. PubMed ID: 4346482
    [No Abstract]   [Full Text] [Related]  

  • 50. Perhydrohistrionicotoxin: a potential ligand for the ion conductance modulator of the acetylcholine receptor.
    Eldefrawi AT; Eldefrawi ME; Albuquerque EX; Oliveira AC; Mansour N; Adler M; Daly JW; Brown GB; Burgermeister W; Witkop B
    Proc Natl Acad Sci U S A; 1977 May; 74(5):2172-6. PubMed ID: 301278
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acetylcholine receptor and ion conductance modulator sites at the murine neuromuscular junction: evidence from specific toxin reactions.
    Albuquerque EX; Barnard EA; Chiu TH; Lapa AJ; Dolly JO; Jansson SE; Daly J; Witkop B
    Proc Natl Acad Sci U S A; 1973 Mar; 70(3):949-53. PubMed ID: 4351811
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alpha-Bungarotoxin enhances transmitter "released" at the neuromuscular junction.
    Miledi R; Molenaar PC; Polak RL
    Nature; 1978 Apr; 272(5654):641-3. PubMed ID: 643060
    [No Abstract]   [Full Text] [Related]  

  • 53. Increasing quantal size at the mouse neuromuscular junction and the role of choline.
    Yu SP; Van der Kloot W
    J Physiol; 1991 Feb; 433():677-704. PubMed ID: 1841963
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Degradation of junctional and extrajunctional acetylcholine receptors by developing rat skeletal muscle.
    Steinbach JH; Merlie J; Heinemann S; Bloch R
    Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3547-51. PubMed ID: 291023
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evoked transmitter release increased by inorganic mercury at frog neuromuscular junction.
    Manalis RS; Cooper GP
    Nature; 1975 Oct; 257(5528):690-1. PubMed ID: 241937
    [No Abstract]   [Full Text] [Related]  

  • 56. Diffusion of acetylcholine in the synaptic cleft of normal and myasthenia gravis human endplates.
    Cull-Candy SG; Miledi R; Uchitel OD
    Nature; 1980 Jul; 286(5772):500-2. PubMed ID: 7402330
    [No Abstract]   [Full Text] [Related]  

  • 57. Endplate current fluctuations reveal only one channel type at frog neuromuscular junction.
    Dionne VE; Ruff RL
    Nature; 1977 Mar; 266(5599):263-5. PubMed ID: 300471
    [No Abstract]   [Full Text] [Related]  

  • 58. Selectivity of bethanechol on muscarinic receptors.
    Burleigh DE
    J Pharm Pharmacol; 1978 Jun; 30(6):398-9. PubMed ID: 26782
    [No Abstract]   [Full Text] [Related]  

  • 59. Acetylcholine receptors.
    Green DP; Miledi R; Perez de la Mora M; Vincent A
    Philos Trans R Soc Lond B Biol Sci; 1975 Jun; 270(908):551-9. PubMed ID: 238250
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The characteristics of 'end-plate noise' produced by different depolarizing drugs.
    Katz B; Miledi R
    J Physiol; 1973 May; 230(3):707-17. PubMed ID: 4717155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.